Local anti-inflammatory properties of etoclofene. A new fenamate derivative.
D000284:Administration, Oral; D000287:Administration, Topical; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use / Q000633:toxicity; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use / Q000633:toxicity; D001593:Benzyl Compounds / Q000008:administration & dosage / Q000627:therapeutic use / Q000633:toxicity; D002351:Carrageenan; D003436:Croton Oil; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy; D005019:Ethyl Ethers / Q000008:administration & dosage / Q000627:therapeutic use / Q000633:toxicity; D005260:Female; D005439:Flufenamic Acid / Q000008:administration & dosage / Q000627:therapeutic use / Q000633:toxicity; D007191:Indazoles / Q000008:administration & dosage / Q000627:therapeutic use / Q000633:toxicity; D007928:Lethal Dose 50; D008297:Male; D008469:Meclofenamic Acid / Q000031:analogs & derivatives; D010653:Phenylbutazone / Q000008:administration & dosage / Q000627:therapeutic use / Q000633:toxicity; D051381:Rats; D014050:Toluene / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use / Q000633:toxicity; D062367:ortho-Aminobenzoates / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use / Q000633:toxicity
D000893:Anti-Inflammatory Agents; D001593:Benzyl Compounds; D005019:Ethyl Ethers; D007191:Indazoles; D062367:ortho-Aminobenzoates; D014050:Toluene; D008469:Meclofenamic Acid; D005439:Flufenamic Acid; D003436:Croton Oil; D002351:Carrageenan; C004688:terofenamate; D010653:Phenylbutazone; D001241:Aspirin